Non-members: Click here to review a complimentary excerpt from " Best Practices in Pharma Medical Education: Structure and Investment"
Medical Education plays a vital role in updating health care professionals with the latest medical knowledge. However, in the face of compliance pressures and dwindling budgets, Medical Education groups within pharmaceutical companies are reshaping their approach to deployment of medical education programs.
Best Practices, LLC, undertook this benchmarking study to inform those that lead medical education functions on the proper structure and funding for this function or group. In addition, the study provides benchmarks around the resources, investment and budget allocation by region and program type and trends in grants to professional societies/associations for accredited and non-accredited education programs.
- Medical Education group structure and activities performed
- The funding channels utilized by Medical Education groups
- Benchmark Medical Education resources, investment allocation and budget allocation by region and program type
- Trends in grants to professional societies/associations for accredited and non-accredited education programs
- Medical Education Groups Organizational Fit
- Professional Medical Education Structural Approach
- Medical Education Leadership & Scope
- Geographic Program Focus
- Approach to Program Content
- Budget Investment Per Year
- Budget as a Percentage of Revenue
- Internal Medical Education Funding Sources
- Budget Allocation Across Regions
- Budget Allocation by Program Type
- Medical Education Funding Allocations
SAMPLE KEY FINDINGS
Medical Education Structure Is Predominantly Centralized:
- More than three-fourths of pharma companies centralize their medical education structure; 46% of them have located their centralized medical education group in the United States.
- Medical Education is a part of professional affairs/medical education at 40% of pharma companies. Professionally, medical education is a part of a larger medical affairs group at 93% of pharma companies.
Best Practices, LLC engaged 15 leaders supporting medical education at 13 leading life sciences companies. More than 50% of participants are at the level of director/ senior director and around 20% of participants are managers. More than 80% of participants were from the United States.